$148 Million is the total value of Samjo Capital LLC's 20 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QUOT | Buy | QUOTIENT TECHNOLOGY INC | $27,511,000 | -29.8% | 2,545,000 | +6.0% | 18.62% | -36.0% |
| PDFS | Buy | PDF SOLUTIONS INC | $24,998,000 | +15.6% | 1,375,000 | +13.1% | 16.92% | +5.5% |
| VG | Sell | VONAGE HLDGS CORP | $11,024,000 | +21.1% | 765,000 | -0.6% | 7.46% | +10.5% |
| ASPN | Buy | ASPEN AEROGELS INC | $10,801,000 | +53.9% | 361,000 | +4.6% | 7.31% | +40.5% |
| INOV | Sell | INOVALON HLDGS INC | $10,394,000 | -8.6% | 305,000 | -22.8% | 7.04% | -16.6% |
| ITI | ITERIS INC NEW | $8,579,000 | +7.8% | 1,290,000 | 0.0% | 5.81% | -1.6% | |
| SCOR | Buy | COMSCORE INC | $7,050,000 | +57.9% | 1,410,000 | +15.6% | 4.77% | +44.1% |
| THRY | Buy | THRYV HLDGS INC | $6,904,000 | +156.6% | 193,000 | +67.8% | 4.67% | +134.1% |
| GTYH | New | GTY TECHNOLOGY HOLDINGS INC | $6,363,000 | – | 895,000 | +100.0% | 4.31% | – |
| NEPH | Sell | NEPHROS INC | $5,630,000 | +53.9% | 549,100 | -0.2% | 3.81% | +40.5% |
| REPH | Buy | RECRO PHARMA INC | $5,013,000 | +220.9% | 2,170,000 | +287.5% | 3.39% | +192.8% |
| GAN | GAN LTD | $4,850,000 | -9.7% | 295,000 | 0.0% | 3.28% | -17.6% | |
| RSSS | Sell | RESEARCH SOLUTIONS INC | $3,146,000 | -7.1% | 1,100,000 | -24.7% | 2.13% | -15.2% |
| HTGM | Buy | HTG MOLECULAR DIAGNOSTICS IN | $3,103,000 | +31.9% | 534,000 | +24.2% | 2.10% | +20.3% |
| XGN | Buy | EXAGEN INC | $3,073,000 | +17.1% | 205,000 | +36.7% | 2.08% | +6.8% |
| FRG | FRANCHISE GROUP INC | $2,116,000 | -2.4% | 60,000 | 0.0% | 1.43% | -10.9% | |
| DMRC | Buy | DIGIMARC CORP NEW | $1,977,000 | +166.4% | 59,000 | +136.0% | 1.34% | +143.3% |
| TACT | TRANSACT TECHNOLOGIES INC | $1,785,000 | +26.3% | 130,000 | 0.0% | 1.21% | +15.3% | |
| ACCELERATE DIAGNOSTICS INCnote 2.500% 3/1 | $1,770,000 | -0.3% | 2,600,000 | 0.0% | 1.20% | -9.0% | ||
| INSE | New | INSPIRED ENTMT INC | $1,658,000 | – | 130,000 | +100.0% | 1.12% | – |
| SHSP | Exit | SHARPSPRING INC | $0 | – | -165,000 | -100.0% | -1.96% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -815,000 | -100.0% | -2.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PDF SOLUTIONS INC | 12 | Q3 2023 | 30.2% |
| THRYV HLDGS INC | 12 | Q3 2023 | 15.9% |
| ASPEN AEROGELS INC | 12 | Q3 2023 | 11.8% |
| ITERIS INC NEW | 12 | Q3 2023 | 14.0% |
| DIGIMARC CORP NEW | 12 | Q3 2023 | 1.3% |
| SOCIETAL CDMO INC | 11 | Q3 2023 | 6.4% |
| COMSCORE INC | 11 | Q3 2023 | 6.3% |
| QUOTIENT TECHNOLOGY INC | 10 | Q2 2023 | 29.1% |
| INSPIRED ENTMT INC | 10 | Q3 2023 | 11.0% |
| FRANCHISE GROUP INC | 10 | Q1 2023 | 4.0% |
View Samjo Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INCSold out | February 10, 2023 | 0 | 0.0% |
| ITERIS, INC. | February 10, 2023 | 3,280,000 | 7.7% |
| Societal CDMO, Inc. | February 10, 2023 | 4,050,000 | 4.8% |
| NEPHROS INC | February 08, 2022 | 425,000 | 4.2% |
| Research Solutions, Inc. | February 08, 2022 | 1,280,000 | 4.8% |
| HTG MOLECULAR DIAGNOSTICS, INC | February 11, 2021 | 381,713 | 8.1% |
| NEPHROS INC | October 21, 2020 | 550,000 | 5.6% |
| ARI NETWORK SERVICES INC /WI | February 10, 2017 | 941,800 | 5.4% |
| Digimarc CORP | February 12, 2016 | 380,200 | 4.3% |
| PRGX GLOBAL, INC. | February 09, 2015 | 1,175,000 | 4.3% |
View Samjo Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-09 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-10 |
| SC 13G/A | 2023-02-10 |
| SC 13G/A | 2023-02-10 |
| SC 13G/A | 2023-02-10 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-04 |
View Samjo Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.